Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists

Details for Australian Patent Application No. 2004230220 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gillespie, Paul; Guertin, Kevin Richard; Erickson, Shawn David

Agent Spruson & Ferguson

Pub. Number AU-B-2004230220

PCT Pub. Number WO2004/092156

Priority 60/463,200 16.04.03 US

Filing date 13 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 17 September 2009

International Classifications

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 333/78 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/092156 Priority application(s): WO2004/092156

17 September 2009 Application Accepted

  Published as AU-B-2004230220

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230224-Process for producing pipe sleeves from mineral wool

2004230209-Quinazoline compounds useful as p38 kinase inhibitors